A modified HIV challenge assay in mice by using luciferase-expressing vaccinia virus

Vaccine. 2006 Apr 5;24(15):2751-4. doi: 10.1016/j.vaccine.2005.12.029. Epub 2005 Dec 28.

Abstract

In this study, we developed a simple and sensitive assay in mice for a challenge experiment by using a recombinant vaccinia virus dual-expressing antigen (HIV Env gp160) and firefly luciferase. This assay can detect the vaccine effect at real-time in vivo by using a small amount of mouse serum. The luciferase activity in mouse serum was in agreement with the viral titer in the ovary. This assay would be applicable as a challenge model for infectious diseases.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / immunology
  • Animals
  • Disease Models, Animal*
  • Female
  • Genes, Reporter
  • HIV / genetics*
  • HIV Envelope Protein gp160 / genetics*
  • HIV Envelope Protein gp160 / immunology
  • HIV Infections*
  • Luciferases / blood
  • Luciferases / genetics*
  • Mice
  • Mice, Inbred BALB C
  • Ovary / virology
  • Sensitivity and Specificity
  • Serum / virology
  • Staining and Labeling / methods
  • Vaccinia virus / genetics*
  • Vaccinia virus / physiology

Substances

  • AIDS Vaccines
  • HIV Envelope Protein gp160
  • Luciferases